Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Share News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Recruitment Firms Drop Amid Weak UK Market

Tue, 08th Oct 2019 10:35

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.

----------

FTSE 100 - WINNERS

----------

St James's Place, up 2.0%. Deutsche Bank raised the wealth manager to Buy from Hold.

----------

FTSE 100 - LOSERS

----------

London Stock Exchange Group, down 5.8%. LSEG said it is making "good" progress on its Refinitiv Holdings Ltd acquisition, shortly after Hong Kong Exchanges & Clearing pulled out of its bid to buy the UK bourse. LSEG noted the announcement by HKEX to not make a formal offer for the group, after initially proposing a potential GBP30 billion takeover offer in mid-September. LSEG initially rejected the offer later that month. At the time of the rejection, LSEG said it saw "fundamental flaws" in the approach, and also noted any combination would come under intense scrutiny from a variety of regulators. On Tuesday, however, HKEX formally announced it had withdrawn its offer to buy the FTSE 100-listed financial exchange operator. HKEX shares closed 2.3% higher at HKD231.20 on Tuesday in Hong Kong.

----------

FTSE 250 - WINNERS

----------

Electrocomponents, up 3.5%. The electrical parts distributor said it expects to report 5% revenue growth in the six months to the end of September, thanks to a continued "strong" performance in its Industrial division - this interim growth comprises of 4% in the first quarter and 5% in the second quarter. Geographically, the FTSE 250-listed company reported further growth of 5% and market share gains in Europe, the Middle East and Africa, despite increased macro uncertainty. Turning to Americas, Electrocomponents said improvements in this region - leading to 3% revenue growth in the first half - were driven primarily by sales force initiatives.

----------

SSP Group, up 1.0%. HSBC raised the travel concessions operator to Buy from Hold.

----------

FTSE 250 - LOSERS

----------

PageGroup, down 9.1%. The recruiter said its third quarter was hurt by political and economic uncertainty in its larger markets, including Greater China, the UK and France. For the quarter ended September 30, gross profit was up 4.2% to GBP216.7 million - at constant currency profit was up 2.1%. Third quarter gross profit for Europe, the Middle East & Africa was up 7%, and the Americas region was up 17%. However, in the UK gross profit was down 4.1% and in the Asia Pacific region it was down 4.0%. Chief Executive Steve Ingram said: "Looking ahead, the deterioration in trading conditions seen during third quarter across the majority of our regions is anticipated to continue. In the UK, heightened Brexit related uncertainty is expected to remain as we approach and go beyond 31 October." Fellow recruitment firm Hays was down 6.3%.

----------

easyJet, down 5.5%. The budget airline said it delivered a "solid" performance in the fourth quarter, continuing to perform in line with expectations. easyJet said it saw "robust" customer demand, with self-help initiatives "driving outperformance" in passenger and ancillary revenue per seat. As a result, easyJet expects headline pretax profit of between GBP420 million and GBP430 million - in the upper half of the airline's guidance range. In the year ending September 30, 2018, the airline recorded GBP578 million in headline pretax profit. "The market appears to have already been expecting EasyJet to issue a fairly bullish statement and so the actual news may not have been as impressive as some investors wanted," commented AJ Bell's Russ Mould. easyJet Chief Executive Johan Lundgren attributed easyJet's increased demand to the "disruption" seen at rivals British Airways and Ryanair Holdings. British Airways is owned by International Consolidated Airlines Group. Fellow airline operators IAG and Ryanair Holdings were down 1.6% and 3.2% respectively.

----------

TalkTalk Telecom Group, down 3.0%. Societe Generale downgraded the home phone and broadband provider to Sell from Hold.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Altyn, up 21%. The gold miner's shares rose following release of a Competent Persons Report for the Sekisovskoye mine in Kazakhstan, revising its resource estimates. The CPR was put together by Ernst & Young Advisory Services, which estimated total ore reserves of 33.5 million tonnes. Proved ore reserves stand at 29.9 million tonnes, containing 3.47 million ounces of gold at a grade of 3.61 grams per tonne, and 5.7 million ounces of silver at a grade of 5.88 grams per tonne. Meanwhile, probable ore reserves was 3.6 million tonnes, containing 330,000 ounces of gold at a grade of 2.91 grams per tonne, and 550,000 ounces of sliver at a grade of 4.81 grams per tonne. The CPR also guided for a net present value of the Sekisovskoye mine at USD415.4 million, up from the USD238.6 million estimated in a CPR published in 2014.

----------

4D Pharma, up 11%. The pharmaceutical company said it has entered into a research collaboration and option licence agreement with Merck & Co to develop vaccines for gut bacteria. 4D develops "live biotherapeutics" to treat the bacteria found in the human intestine - or gut microbiomes. The development of treatments for gut microbiome, 4D said, leads to treatments for cancer, gastrointestinal disease, respiratory disease and central nervous system disease. 4D said it could receive up to USD347.5 million as part of the deal, if certain option exercises and regulatory milestone payments are met. The deal will also include tiered royalties from the sales of any products created from the collaboration. MSD will be responsible for development, manufacturing and commercialisation following the exercise of any of its exclusive options. Under the deal, 4D's MicroRx platform will be used by MSD in three undisclosed indications, to discover if the drug can be commercialised.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Robert Walters, down 7.2%. The recruiter said net fee income growth slowed to 2% at constant currency in the third quarter, as international growth offset a weak UK market. In the first half, Robert Walters reported net fee income jumped 8.6% on a reported and 7% on a constant currency basis after all of its regions delivered growth. In the third quarter, however, net fee income shrank 11% within its home UK market after client and job candidate confidence weakened during ongoing Brexit uncertainty. "The fact that PageGroup and Robert Walters have both warned about major headwinds in the recruitment space and reported a big slowdown in earnings growth shouldn't be a surprise. The large amount of gloomy economic data including deteriorating purchasing managers' indices should give you some very strong clues about corporate confidence. Companies presented with a negative backdrop will think hard about their spending and that includes staff costs," said AJ Bell's Mould.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
15 Feb 2023 14:21

IN BRIEF: 4D Pharma shares cancelled from trading on London's AIM

4D Pharma PLC - Leeds-based pharmaceutical firm - Notes cancellation of its shares on AIM from Thursday, after it entered into administration in June 2022.

Read more
3 Feb 2023 15:17

TRADING UPDATES: GCP Infra hails NAV rise; Jadestone profits from oil

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Jan 2023 15:58

UK shareholder meetings calendar - next 7 days

Tuesday 10 January 
Valereum Blockchain PLCAGM
Wishbone Gold PLCAGM
Wednesday 11 January 
AB Dynamics PLCAGM
Asos PLCAGM
Edge Performance VCT PLCGM re deed of release
Hurricane Energy PLCAGM
Induction Healthcare Group PLCAGM
MetalNRG PLCGM requisitioned to remove chair and CEO from board
Synthomer PLCGM re sale of laminates business
Thursday 12 January 
JPMorgan Japanese Investment Trust PLCAGM
Friday 13 January 
eEnergy Group PLCGM re shareholder resolution to adopt the 2022 Accounts
Monday 16 January 
4D Pharma PLCGM re update on administration and suspension of trading
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
30 Dec 2022 17:21

4D Pharma seeks approval for equity fundraise to lift suspension

(Alliance News) - 4D Pharma PLC on Friday said it was seeking shareholder approval for a USD15.0 million cash raise, as it works to lift its suspension and restore its shares to trading.

Read more
16 Nov 2022 17:00

4D Pharma says trial results show Blautix eases IBS symptoms

(Alliance News) - 4D Pharma PLC said on Wednesday that its Blautix phase 2 clinical trial results showed the treatment had a positive effect on sufferers of irritable bowel syndrome

Read more
24 Aug 2022 11:44

IN BRIEF: 4D Pharma publishes pre-clinical research for autism

4D Pharma PLC - Leeds, England-based pharmaceutical company - Releases its publication of pre-clinical research on mice regarding live biotherapeutic MRx0006 for the treatment of autism spectrum disorder. Says research shows LBP MRx0006 can attenuate core behavioural deficits in a mouse model of autism, improving social deficits, repetitive and anxiety-like behaviours. "Mechanistically, MRx0006 increased in the brains of ASD mice the expression of neuropeptide hormones known to regulate social and anxiety behaviour," 4D Pharma adds.

Read more
5 Aug 2022 14:58

TRADING UPDATES: 4D Pharma warns of wind-up; Star Phoenix files claim

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Wednesday and not separately reported by Alliance News:

Read more
1 Jul 2022 20:05

TRADING UPDATES: Capital wins contracts; 4D pharma pauses enrolment

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Friday and not separately reported by Alliance News:

Read more
28 Jun 2022 21:23

IN BRIEF: 4D Pharma shares to be delisted from Nasdaq

4D Pharma PLC - Leeds, England-based pharmaceutical company - Says it has received written notice from the Nasdaq Stock Market that its securities will be delisted from Nasdaq. Accordingly, trading of its shares will be suspended from the opening of business on July 7. Nasdaq staff cited 4D's announcement that it had been placed into administration on Friday as raising "public interest concerns". The exchange also mentioned concerns regarding the residual equity interest of existing shareholders of listed securities.

Read more
24 Jun 2022 19:09

IN BRIEF: 4d Pharma faces uncertain future as loan repayment due

4d Pharma PLC - Leeds, England-based pharmaceutical company - Says it has "no immediate certainty" of how it will repay the USD13.9 million loan facility it has with Oxford Finance LLC.

Read more
24 Jun 2022 14:33

IN BRIEF: 4d Pharma suspends trading immediately, pending announcement

4d Pharma PLC - Leeds, England-based pharmaceutical company - Says it has ordered an immediate suspension of trading in the company's shares on AIM pending a further announcement.

Read more
24 Jun 2022 12:35

4D Pharma requests immediate suspension of its shares

(Sharecast News) - Biotherapeutics developer 4D Pharma requested an immediate suspension of trading in its shares on Friday.

Read more
21 Jun 2022 16:05

UK shareholder meetings calendar - next 7 days

Wednesday 22 June 
ASA International Group PLCAGM
Atalaya Mining PLCAGM
Bonhill Group PLCAGM
Chapel Down Group PLCAGM
Churchill China PLCAGM
Downing Renewables & Infrastructure Trust PLCGM re share issue
Ecofin US Renewables Infrastructure Trust PLCAGM
EJF Investments LtdAGM
Frenkel Topping Group PLCAGM
Good Energy Group PLCAGM
Honeycomb Investment Trust PLCAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Intelligent Ultrasound Group PLCAGM
Iofina PLCAGM
John Wood Group PLCAGM
Kingfisher PLCAGM
LXi REIT PLCGM
Menhaden PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Pennant International Group PLCAGM
Plant Health Care PLCAGM
Skillcast Group PLCAGM
Team PLCAGM
Tribal Group PLCGM re final dividend
Trident Royalties PLCAGM
Vertu Motors PLCAGM
Wentworth Resources PLCAGM
Thursday 23 June 
Avacta Group PLCAGM
Anglo Asian Mining PLCAGM
Card Factory PLCAGM
Cordiant Digital Infrastructure LtdAGM
Downing Renewables & Infrastructure Trust PLCGM re initial placing & open offer
Eight Capital Partners PLCGM re aligning 2022 bonds with 2026 bonds
GENinCode PLCAGM
Ideagen PLCGM re takeover by Hg Pooled Management Ltd
Longboat Energy PLCAGM
Oxford Nanopore Technologies PLCAGM
Puma VCT 13 PLCGM re cancellation of listing & liquidation
RBG Holdings PLCAGM
Tandem Group PLCAGM
Union Jack Oil PLCAGM
Zinnwald Lithium PLCAGM
Friday 24 June 
AFC Energy PLCGM re fees for non-executive directors
Avast PLCAGM
Devolver Digital IncAGM
Entain PLCAGM
Gulf Keystone Petroleum LtdAGM
Hawkwing PLCAGM
Invesco Bond Income Plus LtdAGM
Life Science REITAGM
Northcoders Group PLCAGM
Princess Private Equity Holding LtdAGM
Monday 27 June 
Anglo-Eastern Plantations PLCAGM
Celadon Pharmaceuticals PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Echo Energy PLCAGM
Medica Group PLCAGM
Pelatro PLCAGM
Surgical Innovations Group PLCAGM
Warpaint London PLCAGM
Tuesday 28 June 
4D Pharma PLCAGM
Acceler8 Ventures PLCAGM
Airtel Africa PLCAGM
Alina Holdings PLCAGM
Aquila Energy Efficiency Trust PLCAGM
Attraqt Group PLCAGM
Bay Capital PLCAGM
Capital & Counties Properties PLCAGM
CMO Group PLCAGM
Corre Energy BVAGM
Creo Medical Group PLCAGM
Futura Medical PLCAGM
Gama Aviation PLCAGM
ICG Enterprise Trust PLCAGM
ImmuPharma PLCAGM
IQE PLCAGM
Katoro Gold PLCAGM
Rockhopper Exploration PLCAGM
Sound Energy PLCAGM
TP Group PLCAGM
UK Oil & Gas PLCAGM
Volvere PLCAGM
Zegona Communications PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
27 May 2022 10:46

4D Pharma reports progress in bladder cancer trial

(Sharecast News) - Live biotherapeutics developer 4D Pharma announced progress in the phase 2 clinical trial in bladder cancer on Friday.

Read more
27 May 2022 09:31

IN BRIEF: 4D Pharma plans to test MRx0518 in combination with Bavencio

4D Pharma PLC - Leeds, England-based pharmaceutical company - Plans to conduct a phase II study to assess the safety of MRx0518 in combination with Bavencio. Says the study will be conducted in patients with unresectable locally advanced or metastatic urothelial carcinoma, a type of bladder cancer. Says previous data about MRx0518 supports the potential of this combination to "significantly enhance and improve" outcomes for patients, beyond treatment with Bavencio alone. Bavencio is an antibody medication for the treatment of urothelial carcinoma.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.